The glucose transporter isoform GLUT4 is found only in cells that exhibit insulin-sensitive glucose transport. To investigate the function of this transporter, L6 myoblasts were stably transfected with GLUT4 cDNA. GLUT4 underwent insulin-dependent movement to the cell surface in myoblasts overexpressing the transporter. One cell line (243-6) expressed sufficient levels of the GLUT4 protein to study insulin-dependent glucose transport. Unlike wild-type L6 cells, 243-6 myoblasts exhibited two features that are characteristic of differentiated muscle fibers and adipocytes in vivo: a large insulin-stimulated component of glucose transport and inhibition of this stimulated component by cAMP. Relative to normal L6 cells, 243-6 cells responded to insulin or insulin-like growth factor 1 with a 5-fold larger increase in 2-deoxy[3Hlglucose uptake. N',02'-Dibutyryladenosine 3',5'-cycic monophosphate (Bt2cAMP) did not inhibit transport in normal L6 myoblasts, which express only GLUT1, but inhibited IGF-1/insulin-stimulated transport by 50% in 243-6 cells. The effect of cAMP was investigated further by using Chinese hamster ovary cells transiently expressing GLUT1 and GLUT4. Bt2cAMP inhibited glucose transport only in Chinese hamster ovary cells expressing GLUT4. These results indicate that cAMP-mediated inhibition of glucose transport is dependent on expression of the GLUT4 isozyme.
243-6 myoblasts exhibited two features that are characteristic of differentiated muscle fibers and adipocytes in vivo: a large insulin-stimulated component of glucose transport and inhibition of this stimulated component by cAMP. Relative to normal L6 cells, 243-6 cells responded to insulin or insulin-like growth factor 1 with a 5-fold larger increase in 2-deoxy[3Hlglucose uptake. N',02'-Dibutyryladenosine 3',5'-cycic monophosphate (Bt2cAMP) did not inhibit transport in normal L6 myoblasts, which express only GLUT1, but inhibited IGF-1/insulin-stimulated transport by 50% in 243-6 cells. The effect of cAMP was investigated further by using Chinese hamster ovary cells transiently expressing GLUT1 and GLUT4. Bt2cAMP inhibited glucose transport only in Chinese hamster ovary cells expressing GLUT4. These results indicate that cAMP-mediated inhibition of glucose transport is dependent on expression of the GLUT4 isozyme.
Insulin causes a marked and rapid increase in glucose transport in adipocytes, skeletal muscle cells, and cardiac myocytes (1, 2) . This acute effect of insulin involves translocation of glucose transporters from an intracellular store to the plasma membrane (3, 4) . ,3-Adrenergic agonists, such as epinephrine and isoproterenol, inhibit insulin-stimulated glucose transport (5) (6) (7) . These inhibitory effects can be observed under conditions in which the level of plasma membrane transporters is not decreased (8, 9) . Glucose transport is also decreased by cAMP derivatives (5, 6) , suggesting that the inhibitory effects of j-adrenergic agonists are mediated by increased cAMP.
GLUT4 is one of five homologous glucose transport proteins (for review, see refs. 10 and 11). GLUT4 is expressed exclusively in those cell types exhibiting the highest levels of insulin-stimulated glucose transport (12, 13) , although these cell types also express smaller amounts of GLUT1, a transporter isoform that has a much wider tissue distribution (14) . GLUT1 is found in relatively high levels in the plasma membrane, where almost no GLUT4 can be detected under basal conditions (15) (16) (17) . Insulin promotes translocation of both transporters to the cell surface (15) (16) (17) ; however, the magnitude of the insulin-dependent increase at the plasma membrane is much greater for GLUT4 than for GLUT1. Thus, GLUT4 appears to be primarily responsible for mediating insulin-stimulated transport in muscle and fat cells.
L6 is a skeletal muscle cell line that has been previously used to investigate the regulation of glucose transport (18) (19) (20) . Insulin stimulates glucose transport in L6 cells, but the magnitude ofthe stimulatory effect (2-fold maximum) is much less than that observed in rat skeletal muscles. Unlike skeletal muscle fibers in vivo, L6 myoblasts express very low levels of GLUT4 (21). The results described in the present report indicate that expression of GLUT4 per se can be sufficient to increase insulin-stimulated glucose transport in L6 myoblasts. In addition, evidence that expression of GLUT4 in L6 myoblasts and Chinese hamster ovary (CHO) cells results in the appearance of cAMP-dependent inhibition of glucose transport is presented. GLUT1 and GLUT4 were transiently expressed in CHO cells by using a Sindbis virus expression system, which enables expression of large amounts of recombinant proteins in eukaryotic cells (24) . The expression vector (KASind) was based on a full-length Sindbis virus cDNA clone (25) containing an additional subgenomic mRNA promoter (26) and an additional cloning site (27) . Virus stocks were produced essentially as described (28 Growth medium was then added and cells were incubated at 370C. Depending on the virus used, GLUT1 or GLUT4 expression was markedly increased after 6 hr of infection, and approximately 50% and 10%o, respectively, of the transporters were determined to be at the cell surface (27) .
MATERIALS AND METHODS
Detection of Glucose Transporters by Immunoblotting. Cells were rinsed twice with solution A, scraped from the dish, and homogenized in solution B (0.25 M sucrose/1 mM EDTA/10 mM NaHepes, pH 7.4; 1 ml per 10-cm dish). Samples of the homogenates were subjected to SDS/PAGE by the method of Laemmli (29) . Proteins were electrophoretically transferred from the 10%o acrylamide gels to nitrocellulose sheets. To identify GLUT4 and GLUT1, the sheets were incubated with polyclonal antibodies (Abs) against synthetic peptides having the sequence of the last 12 amino acids in the COOH termini ofthe respective transporters. Transporters were detected by using 1251I-labeled protein A and autoradiography (9) .
Etimation of Glucose Transport Activity. Myoblasts were seeded into 24-well culture dishes (Falcon). After 4-6 days of culture, the cells were incubated for 5 hr at 37°C in DMEM without serum (18 remove excess fixative. Coverslips were then incubated at 4°C for -18 hr with the GLUT4 Ab (50 ,g/ml), washed, and incubated for 50 min with fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit Ab (Cappel Laboratories). Next the specimens were washed and again fixed using paraformaldehyde before being incubated with an antiserum (1:100 dilution) to rat Na+,K+-ATPase (supplied by Robert Mercer, Washington University). After incubation with rhodamine-labeled goat antirabbit IgG (Cappel), the coverslips were washed and mounted in solution A supplemented with 10%1o glycerol and 1% n-propyl gallate (Sigma). Lawns were examined with a Zeiss Axioplan microscope equipped with a Bio-Rad MRC-500 laser confocal imaging system. Images ofintact cells were obtained as described (16) . the transporter at a level approaching that in muscle or fat cells. However, one clone (designated 243-6) having a point mutation at position 243 expressed transporter protein at a level comparable to that in rat heart (Fig. 1) , which has the highest levels of GLUT4 of any tissue that has been examined (13) . Levels of GLUT1 were comparable in normal L6 cells and 243-6 cells. Because of the extremely high level of GLUT4 expression, 243-6 cells were investigated further.
RESULTS

Overexpression of GLUT4 Potentiates
Glucose transport was assessed in normal L6 and 243-6 cells by measuring the rate of uptake of 2-deoxy[3H]glucose. Uptake was linear for 30 min in cells from both lines (Fig. 2) and was almost completely inhibited by cytochalasin B, an inhibitor of glucose transport. The rate of uptake in the absence of insulin was not significantly different in L6 cells and 243-6 cells. However, the increment in 2-deoxy[3H]-glucose uptake due to insulin was five times higher in the cells overexpressing GLUT4 than in the normal L6 cells.
IGF-1 also increased 2-deoxy[3H]glucose uptake severalfold in 243-6 cells (Fig. 3) , with the maximum effect representing an increase of -6-fold over basal. Insulin receptors have higher affinity for insulin than for IGF-1, and IGF-1 receptors bind IGF-1 with an affinity -50 times higher than that for insulin (32, 33 (23, 27, 35) . Upon treatment of cells with insulin or IGF-1, we observed an increase in plasma membrane labeling for GLUT4 but no change in labeling of the Na',K+-ATPase (Fig. 4) . Quantitation of fluorescence from digitized images showed a 3-fold increase in GLUT4 at the cell surface. This insulin-or IGF-1-dependent movement of GLUT4 to the cell surface was not due to the mutation at position 243 because we observed a 3-fold increase in cell surface labeling for GLUT4 in L6 cells transfected with cDNA encoding wild-type transporter (results not shown).
Bt2cAMP Inhibition of Glucose Transport. Increasing cAMP is associated with inhibition of insulin-sensitive glu- cose transport in cells that express GLUT4 in vivo. To investigate the possibility that the inhibitory effect was mediated specifically by the GLUT4 isoform, the effects of Bt2cAMP on 2-deoxy[3H]glucose uptake were assessed in L6 cells and 243-6 cells (Fig. 5) (27) . Uptake of 2-deoxy[3H]glucose was increased by 2-fold and 3-fold in CHO cells overexpressing GLUT4 and GLUT1, respectively (Fig. 6 ). These increases in uptake were due to expression of the transporters as opposed to viral infection per se because there was no significant increase in uptake in CHO cells infected with control virus. Bt2cAMP markedly inhibited 2-deoxy[3HHWucose uptake in cells expressing GLUT4 but was without effect in mockinfected cells or in cells overexpressing GLUT1.
DISCUSSION
Overexpression of GLUT4 in L6 cells resulted in two major functional changes in glucose transport. IGF-1/insulinstimulated glucose transport was increased severalfold (Figs.  2, 3 , and 5), and stimulated transport became sensitive to inhibition by cAMP derivatives (Fig. 5) . The inhibitory effect of cAMP was not due to clonal selection of an atypical L6 cell line or to the point mutation at position 243, because Bt2cAMP also inhibited transport in a population of CHO cells transiently expressing wild-type GLUT4. That transport was not inhibited in normal L6 cells or in CHO cells transiently expressing GLUT1 strongly suggests that increased cAMP specifically inhibits glucose transport mediated by GLUT4. (9) . Furthermore, although GLUT1 (8, 34) and GLUT4 (9) are phosphorylated in fat cells, only GLUT4 phosphorylation is increased in response to agents that increase intracellular cAMP. The present findings are consistent with the hypothesis that phosphorylation of GLUT4 accounts for the inhibition of insulin-stimulated glucose transport by cAMP.
Expression of GLUT4 in 243-6 cells led to a marked increase in IGF-1/insulin-stimulated glucose transport, consistent with the key role of GLUT4 in mediating insulinstimulated transport in vivo. The exclusion of GLUT4 from the plasma membrane in basal cells is one factor that contributes to the striking increase in this transporter at the cell surface following treatment with insulin (35, 36) . A second factor is the ability of GLUT4 to move to the plasma membrane in response to insulin. Previous investigations of GLUT4 translocation have relied on differential centrifugation to isolate plasma membranes and intracellular membranes. However, adequate separation of these membranes for studying GLUT4 translocation in myoblasts and fibroblasts has been difficult. Therefore, we used a different method involving sonication of cells to generate plasma membrane fragments. By deep-etch freeze-fracture electron microscopy, these fragments, which remain attached to the substratum, appear to contain only elements that are characteristic of the plasma membrane, such as clathrin-coated pits, caveoli, and cytoskeletal attachments (31) . The levels of GLUT4 in these fragments were increased severalfold after IGF-1/insulin treatment (Fig. 4) , suggesting that translocation of GLUT4 to the plasma membrane accounts for the increase in the IGF-1/insulin-stimulated component of 2-deoxy[3H]glucose uptake observed in the transfected cells.
The magnitude of the hormone-stimulated increase in cells expressing only GLUTi is limited by the high levels of this transporter that are present in the plasma membrane even in the absence of insulin. This limitation probably explains why insulin/IGF-1 elicited a relatively small increase in glucose transport in the normal L6 myoblasts, which express GLUTi (20, 21) . However, expression of GLUT4 per se is not sufficient to produce insulin-stimulated transport in all cells. Insulin was unable to stimulate transport in 3T3 Li fibroblasts overexpressing GLUT4 (23) . Untransfected 3T3 Li fibroblasts and L6 myoblasts are similar in that both express GLUT1. A difference between these cell types is that insulin stimulates glucose transport by as much as 2-fold in L6 cells, presumably due to translocation of GLUTi (20) , whereas insulin does not stimulate transport or translocation of GLUT1 in 3T3 Li fibroblasts (37) . In L6 cells GLUT4 may utilize the same vesicular transport system that moves GLUTi to the plasma membrane in response to insulin. Alternatively, there might be unknown features of the L6 cells that enable GLUT4 to induce components required for its translocation.
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